Market Tracker

10/24 6:05pm ET

Synageva BioPharma Corp (NASDAQ:GEVA)

76.97
Data as of Oct 24
 +0.88 / +1.16%
Today’s Change
44.54
Today|||52-Week Range
119.42
+18.93%
Year-to-Date

Today’s Trading

Previous close76.09
Today’s open76.55
Day’s range75.22 - 77.15
Volume130,216
Average volume (3 months)259,189
Market cap$2.6B
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)-78.95%
Earnings growth (this year)-81.14%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)-10.57%
P/E ratioNM
Price/Sales135.92
Price/Book5.50

Competitors

 Today’s
change
Today’s
% change
XONIntrexon Corp-0.17-0.82%
OPHTOphthotech Corp-0.12-0.30%
KITEKite Pharma Inc-0.60-1.77%
NVAXNovavax Inc+0.14+2.81%
Data as of 4:03pm ET, 10/24/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)-$1.65
Annual revenue (last year)$13.4M
Annual profit (last year)-$95.5M
Net profit margin-713.70%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Sanj K. Patel
Chief Operating Officer
Robert B. Bazemore
Corporate headquarters
Lexington, Massachusetts

Forecasts